Skip to main content
Clinical Trials/NCT04666727
NCT04666727RecruitingNot Applicable

The Role of Diet and the Microbiome in Inducing Somatic Mutations in Colorectal Epithelial Cells and Its Predisposition to Carcinogenesis - A Pilot Study

M.D. Anderson Cancer Center2 sites in 1 country30 target enrollmentStarted: September 29, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
2
Primary Endpoint
Dietary patterns

Study Overview

Brief Summary

This study is to learn more about how diet affects the microbiome (bacteria and microorganisms) of the digestive system. Researchers want to learn if this, in turn, has an effect on if and how people then develop colorectal cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. To evaluate the differences in dietary patterns among individuals reporting to be vegetarian and omnivorous.

II. To compare the difference in stool microbiome pattern in the above mentioned two groups of individuals.

III. To compare somatic mutations in colorectal epithelial cells in the above mentioned two groups of individuals.

SECONDARY OBJECTIVE:

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
45 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • GROUP I: Patients presenting for a screening colonoscopy
  • GROUP I: Age of 45 and above
  • GROUP I: Strict vegetarian diet, determined by using diet history questionnaire 3.0 National Institutes of Health (NIH)
  • GROUP I: Non smoker
  • GROUP I: Ability to understand and willingness to sign an informed consent form, complete web based dietary assessment and provide stool, colonic mucosa and blood samples
  • GROUP II: Patients presenting for a screening colonoscopy
  • GROUP II: Age of 45 and above
  • GROUP II: Omnivorous diet
  • GROUP II: Non smoker
  • GROUP II: Ability to understand and willingness to sign an informed consent form, complete web based dietary assessment and provide stool, colonic mucosa and blood sample

Exclusion Criteria

  • • Current smokers (nicotine abuse only)
  • Positive family history of colon cancer or colon cancer related syndromes
  • Recent use of antibiotics in 1 month
  • History of inflammatory bowel disease, and/or radiation enteritis or colitis
  • Pregnant and breastfeeding women
  • Women of child-bearing potential who have positive urine or serum pregnancy test
  • Heavy drinker (defined as more than 14 drinks per week)
  • Currently using anti-flatulence medications, probiotics and/or fiber supplements
  • Major dietary restrictions and/or following a special diet
  • Patient with positive fecal test/symptoms

Outcomes

Primary Outcomes

Dietary patterns

Time Frame: Baseline

Will obtain estimates of dietary patterns from colonic mucosal biopsies in each group.

Microbiome composition

Time Frame: Baseline

Will obtain estimates of microbiome composition from colonic mucosal biopsies in each group. Microbiome composition will be quantified using 16S profiling will be visualized across samples using stacked bar plots and principal coordinate analysis of the weighted Unifrac distances, and microbiome diversity within each sample will be quantified using the inverse-Simpson index.

Somatic mutation burden

Time Frame: Baseline

Will obtain estimates of somatic mutation burden from colonic mucosal biopsies in each group.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials